Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
An update on Drug Repurposing: Re-written saga of the drug's fate
Hema G. N. S. Sree et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer
Abhinav Gupta et al.
ORAL ONCOLOGY (2019)
Camptothecin activates SIRT1 to promote lipid catabolism through AMPK/FoxO1/ATGL pathway in C2C12 myogenic cells
Mei-Chen Lo et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death
Marwan Ibrahim Abdullah et al.
SCIENTIFIC REPORTS (2019)
2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met
Naeun Lee et al.
METABOLITES (2019)
Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
Eunae Sandra Cho et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling
Lihua Dai et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Overexpression of Forkhead Box O3a and Its Association With Aggressive Phenotypes and Poor Prognosis in Human Hepatocellular Carcinoma
Hyein Ahn et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway
Yingying Jin et al.
EXPERIMENTAL CELL RESEARCH (2018)
Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
Colin H. Beckwitt et al.
PLOS ONE (2018)
ROS-mediated activation of AMPK plays a critical role in sulforaphane-induced apoptosis and mitotic arrest in AGS human gastric cancer cells
Yung Hyun Choi
GENERAL PHYSIOLOGY AND BIOPHYSICS (2018)
Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity
Walied A. Kamel et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis
Zhongrun Qian et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
FOXO transcription factors at the interface of metabolism and cancer
Wolfgang Link et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways
Marisa Granato et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
Sin-Ting Wang et al.
CELL DEATH & DISEASE (2017)
Phosphorylation and acetylation modifications of FOXO3a: Independently or synergistically?
Xianwang Wang et al.
ONCOLOGY LETTERS (2017)
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
Yusuke Kobayashi et al.
ONCOTARGET (2017)
Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin-Induced Cell Cycle Arrest and Apoptosis in Cancer Cells
Anup Shrestha et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway
Tingting Wang et al.
ONCOTARGET (2016)
Nano-biomechanical Validation of Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinomas
Soyeun Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Roberto Wuerth et al.
DRUG DISCOVERY TODAY (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
Adam R. Wolfe et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells
Hao Liu et al.
ANTI-CANCER DRUGS (2014)
The Essential Role of p53-up-regulated Modulator of Apoptosis ( Puma) and Its Regulation by FoxO3a Transcription Factor in β- Amyloid- induced Neuron Death
Rumana Akhter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
Eveline A. I. F. Queiroz et al.
PLOS ONE (2014)
Statin use in primary inflammatory breast cancer: a cohort study
T. M. Brewer et al.
BRITISH JOURNAL OF CANCER (2013)
N-acetylcysteine (NAC) inhibits cell growth by mediating the EGFR/Akt/HMG box-containing protein 1 (HBP1) signaling pathway in invasive oral cancer
Ming-Fen Lee et al.
ORAL ONCOLOGY (2013)
Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients
Xiao-bo Yang et al.
PLOS ONE (2013)
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects
Robert P. Takes et al.
ORAL ONCOLOGY (2012)
Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
Laurie Ma et al.
PLOS ONE (2012)
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Dipika Bansal et al.
PLOS ONE (2012)
Regulation of FOXO protein stability via ubiquitination and proteasome degradation
Haojie Huang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
Guri Tzivion et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Akt, FoxO and regulation of apoptosis
Xinbo Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation Modulation of Molecular Pathways of Radioresistance and Tumor Suppression
Toran Sanli et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
Min Fei et al.
CANCER INVESTIGATION (2009)
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
Silvia Fernandez de Mattos et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Fluvastatin induces apoptosis on human tongue carcinoma cell line HSC-3
Kimiko Fujiwara et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2008)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor
Eric L. Greer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia
ZH Zeng et al.
CANCER RESEARCH (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons
J Gilley et al.
JOURNAL OF CELL BIOLOGY (2003)
Share Paper
